NVST
Envista Holdings Corp NYSE Listed Sep 18, 2019$23.35
-1.44%
vs $23.69
Mkt Cap $4.0B
52w Low $18.95
38.9% of range
52w High $30.26
50d MA $26.94
200d MA $25.53
P/E (TTM)
40.3x
EV/EBITDA
12.2x
P/B
1.3x
Debt/Equity
0.6x
ROE
1.5%
P/FCF
17.1x
RSI (14)
21.60
ATR (14)
$0.87
Beta
0.98
50d MA
$26.94
200d MA
$25.53
Avg Volume
2.7M
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
200 S Kraemer Blvd Bldg E · Brea, CA 92821-6208 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | AMC | 0.34 | 0.41 | +22.3% | 28.63 | +0.2% | -4.4% | +2.8% | +0.1% | +1.2% | +0.7% | — |
| May 6, 2026 | AMC | 0.31 | 0.36 | +16.1% | 27.07 | +8.4% | -10.3% | -0.2% | -0.2% | +0.3% | -1.5% | — |
| Feb 5, 2026 | AMC | 0.32 | 0.38 | +18.8% | 24.71 | +13.0% | +17.8% | +0.9% | +2.8% | +0.3% | -4.9% | — |
| Oct 29, 2025 | AMC | 0.27 | 0.32 | +18.5% | 19.98 | +3.1% | +0.8% | +1.0% | -1.3% | +0.3% | +0.0% | — |
| Jul 31, 2025 | AMC | 0.24 | 0.26 | +8.3% | 18.89 | +7.1% | +10.3% | -1.7% | -2.0% | -1.8% | +1.9% | — |
| May 1, 2025 | AMC | 0.20 | 0.24 | +20.0% | 16.34 | +4.7% | +4.0% | -0.1% | -3.4% | +2.7% | +5.5% | — |
| Feb 5, 2025 | AMC | 0.23 | 0.24 | +4.3% | 20.57 | +9.2% | +5.9% | -2.5% | -0.1% | -1.0% | -0.8% | — |
| Oct 30, 2024 | AMC | 0.09 | 0.12 | +33.3% | 19.23 | +14.4% | +9.0% | -0.1% | +1.6% | -0.8% | +3.7% | — |
| Aug 7, 2024 | AMC | 0.27 | 0.11 | -59.3% | 15.30 | -0.5% | +7.8% | -1.9% | +0.2% | +4.7% | +1.9% | — |
| May 1, 2024 | AMC | 0.31 | 0.26 | -16.1% | 19.75 | -7.3% | +0.3% | -4.1% | +0.3% | -0.3% | -0.9% | — |
| Feb 7, 2024 | AMC | 0.33 | 0.29 | -12.1% | 24.24 | -9.2% | -7.4% | -2.2% | +3.9% | -3.9% | +1.1% | — |
| Nov 1, 2023 | AMC | 0.46 | 0.43 | -6.5% | 22.99 | -11.9% | -7.6% | +4.0% | -3.5% | +0.6% | +1.1% | — |
| Aug 2, 2023 | AMC | 0.41 | 0.43 | +4.9% | 33.92 | +1.7% | +1.0% | -1.8% | +3.9% | -1.5% | -3.2% | — |
| May 3, 2023 | AMC | 0.41 | 0.38 | -7.3% | 37.64 | -13.5% | -6.9% | +0.8% | -1.5% | -0.9% | -1.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3 | JP Morgan | Upgrade | Neutral → Overweight | $32 | $27.39 | $28.27 | +3.2% | +0.7% | -1.1% | -1.7% | -1.5% | -2.1% |
| Jul 9 | BMO Capital Markets | Initiates | Market Perform | $27 | $25.74 | $25.79 | +0.2% | +0.1% | +0.6% | +1.2% | -0.4% | +2.3% |
| Apr 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $27.04 | $27.23 | +0.7% | -0.9% | -0.1% | -1.0% | -2.2% | +0.2% |
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $25.29 | $26.68 | +5.5% | +5.4% | +0.0% | -1.0% | +2.0% | +1.7% |
| Feb 11 | Barclays | Maintains | Overweight → Overweight | — | $30.17 | $30.22 | +0.2% | +0.3% | -4.9% | +0.7% | -3.1% | +1.5% |
| Feb 10 | Mizuho | Maintains | Neutral → Neutral | — | $29.36 | $29.53 | +0.6% | +2.8% | +0.3% | -4.9% | +0.7% | -3.1% |
| Feb 6 | Piper Sandler | Maintains | Neutral → Neutral | — | $24.71 | $27.91 | +13.0% | +17.8% | +0.9% | +2.8% | +0.3% | -4.9% |
| Feb 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $24.71 | $27.91 | +13.0% | +17.8% | +0.9% | +2.8% | +0.3% | -4.9% |
| Feb 6 | Stifel | Maintains | Buy → Buy | — | $24.71 | $27.91 | +13.0% | +17.8% | +0.9% | +2.8% | +0.3% | -4.9% |
| Feb 6 | JP Morgan | Maintains | Neutral → Neutral | — | $24.71 | $27.91 | +13.0% | +17.8% | +0.9% | +2.8% | +0.3% | -4.9% |
| Feb 4 | Stifel | Maintains | Buy → Buy | — | $22.91 | $23.26 | +1.5% | +3.3% | +4.4% | +17.8% | +0.9% | +2.8% |
| Feb 3 | UBS | Maintains | Neutral → Neutral | — | $23.26 | $23.36 | +0.4% | -1.5% | +3.3% | +4.4% | +17.8% | +0.9% |
| Jan 30 | Piper Sandler | Maintains | Neutral → Neutral | — | $23.39 | $23.33 | -0.3% | +0.3% | -0.9% | -1.5% | +3.3% | +4.4% |
| Jan 20 | Mizuho | Upgrade | Underperform → Neutral | — | $25.24 | $25.23 | -0.0% | -3.6% | +1.4% | -1.1% | -2.3% | +0.9% |
| Dec 16 | JP Morgan | Maintains | Neutral → Neutral | — | $22.06 | $22.01 | -0.2% | -0.7% | -0.2% | +1.8% | +0.1% | +0.7% |
| Aug 1 | Piper Sandler | Maintains | Neutral → Neutral | — | $18.89 | $20.24 | +7.1% | +10.3% | -1.7% | -2.0% | -1.8% | +1.9% |
| Aug 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $18.89 | $20.24 | +7.1% | +10.3% | -1.7% | -2.0% | -1.8% | +1.9% |
| Aug 1 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $18.89 | $20.24 | +7.1% | +10.3% | -1.7% | -2.0% | -1.8% | +1.9% |
| Aug 1 | Stifel | Maintains | Buy → Buy | — | $18.89 | $20.24 | +7.1% | +10.3% | -1.7% | -2.0% | -1.8% | +1.9% |
| Aug 1 | Mizuho | Maintains | Underperform → Underperform | — | $18.89 | $20.24 | +7.1% | +10.3% | -1.7% | -2.0% | -1.8% | +1.9% |
| Jul 29 | UBS | Maintains | Neutral → Neutral | — | $20.74 | $20.79 | +0.2% | -2.1% | -1.7% | -5.4% | +10.3% | -1.7% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $20.15 | $20.29 | +0.7% | +1.1% | +1.7% | -2.5% | -0.8% | -1.1% |
| May 27 | Baird | Upgrade | Neutral → Outperform | — | $16.72 | $17.03 | +1.9% | +7.7% | +2.9% | -0.4% | -1.0% | -0.9% |
| May 5 | UBS | Maintains | Neutral → Neutral | — | $16.99 | $16.78 | -1.2% | -0.1% | -3.4% | +2.7% | +5.5% | -1.0% |
| May 2 | Baird | Maintains | Neutral → Neutral | — | $16.34 | $17.10 | +4.7% | +4.0% | -0.1% | -3.4% | +2.7% | +5.5% |
| Apr 30 | Piper Sandler | Maintains | Neutral → Neutral | — | $16.20 | $15.71 | -3.0% | -0.7% | +1.6% | +4.0% | -0.1% | -3.4% |
| Apr 29 | BofA Securities | Maintains | Buy → Buy | — | $15.96 | $15.95 | -0.1% | +1.5% | -0.7% | +1.6% | +4.0% | -0.1% |
| Mar 10 | UBS | Maintains | Neutral → Neutral | — | $18.43 | $18.18 | -1.4% | -5.0% | -2.2% | -2.3% | -2.9% | +2.5% |
| Mar 6 | Needham | Maintains | Hold → Hold | — | $18.24 | $17.88 | -2.0% | -2.2% | +3.4% | -5.0% | -2.2% | -2.3% |
| Mar 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $18.24 | $17.88 | -2.0% | -2.2% | +3.4% | -5.0% | -2.2% | -2.3% |
| Mar 6 | JP Morgan | Maintains | Neutral → Neutral | — | $18.24 | $17.88 | -2.0% | -2.2% | +3.4% | -5.0% | -2.2% | -2.3% |
| Feb 25 | Needham | Maintains | Hold → Hold | — | $21.39 | $21.38 | -0.0% | -3.4% | +0.3% | -4.2% | +0.6% | -4.8% |
| Feb 6 | Baird | Maintains | Neutral → Neutral | — | $20.57 | $22.47 | +9.2% | +5.9% | -2.5% | -0.1% | -1.0% | -0.8% |
| Feb 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $20.57 | $22.47 | +9.2% | +5.9% | -2.5% | -0.1% | -1.0% | -0.8% |
| Feb 6 | Needham | Maintains | Hold → Hold | — | $20.57 | $22.47 | +9.2% | +5.9% | -2.5% | -0.1% | -1.0% | -0.8% |
| Feb 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $20.57 | $22.47 | +9.2% | +5.9% | -2.5% | -0.1% | -1.0% | -0.8% |
| Feb 3 | Piper Sandler | Maintains | Neutral → Neutral | — | $20.52 | $20.03 | -2.4% | -2.4% | +0.5% | +2.2% | +5.9% | -2.5% |
| Jan 23 | Jefferies | Maintains | Hold → Hold | — | $21.05 | $21.34 | +1.4% | +1.2% | +0.7% | +0.7% | +0.8% | -1.8% |
| Oct 31 | Baird | Maintains | Neutral → Neutral | — | $19.23 | $22.00 | +14.4% | +9.0% | -0.1% | +1.6% | -0.8% | +3.7% |
| Oct 31 | Piper Sandler | Maintains | Neutral → Neutral | — | $19.23 | $22.00 | +14.4% | +9.0% | -0.1% | +1.6% | -0.8% | +3.7% |
| Oct 31 | Leerink Partners | Upgrade | Underperform → Market Perform | — | $19.23 | $22.00 | +14.4% | +9.0% | -0.1% | +1.6% | -0.8% | +3.7% |
| Oct 23 | Stifel | Maintains | Buy → Buy | — | $18.66 | $18.59 | -0.4% | +2.3% | -0.4% | -0.7% | +1.8% | -2.3% |
| Sep 23 | Evercore ISI | Maintains | Outperform → Outperform | — | $19.00 | $19.60 | +3.2% | +0.3% | -1.2% | -1.1% | +3.3% | +2.6% |
| Aug 8 | BofA Securities | Maintains | Buy → Buy | — | $15.30 | $15.23 | -0.5% | +7.8% | -1.9% | +0.2% | +4.7% | +1.9% |
| Aug 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $15.30 | $15.23 | -0.5% | +7.8% | -1.9% | +0.2% | +4.7% | +1.9% |
| Aug 8 | JP Morgan | Downgrade | Overweight → Neutral | — | $15.30 | $15.23 | -0.5% | +7.8% | -1.9% | +0.2% | +4.7% | +1.9% |
| Jul 30 | Stifel | Maintains | Buy → Buy | — | $16.42 | $16.12 | -1.8% | +2.9% | +1.0% | -0.8% | -1.6% | -5.3% |
| Jul 30 | Piper Sandler | Maintains | Neutral → Neutral | — | $16.42 | $16.12 | -1.8% | +2.9% | +1.0% | -0.8% | -1.6% | -5.3% |
| Jul 22 | Baird | Maintains | Neutral → Neutral | — | $16.57 | $16.39 | -1.1% | -1.5% | -0.4% | +0.2% | -1.1% | +1.2% |
| Jun 25 | Evercore ISI | Maintains | Outperform → Outperform | — | $16.93 | $16.77 | -0.9% | -5.5% | +3.2% | -0.2% | +0.9% | -3.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Reis MischaOff | SVP, Strategy & Bus. Dev. | Sell | 8,000 | $27.50 | $220K | 27,321 | +0.48% | +0.04% |
8-K · 7.01
! Medium
Envista Holdings Corp -- 8-K 7.01: Regulation FD Disclosure
Sep 17
8-K · 5.02
!!! Very High
Envista Holdings Corp -- 8-K 5.02: Executive Change
Aug 19
8-K · 2.02
!! High
Envista Holdings Corp -- 8-K 2.02: Earnings Results
Aug 5
8-K · 5.02
!!! Very High
Envista Holdings Corp -- 8-K 5.02: Executive Change
Envista Holdings replaced its Chief Accounting Officer with a new Vice President appointment, signaling potential changes in financial leadership and accounting oversight at the dental products company.
Jun 3
8-K · 7.01
! Medium
Envista Holdings Corporation Common stock, $0.01 par value per share -- 8-K 7.01: Regulation FD Disclosure
Envista Holdings will present fourth-quarter 2025 financial results via conference call using a slide deck available on its investor website for stakeholder review.
Feb 5
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 18,437,542 | $486M | New | Jun 2026 |
| 2 | Morgan Stanley | 17,618,488 | $382M | Reduced | Dec 2025 |
| 3 | Ariel Investments, Llc | 10,863,592 | $276M | Reduced | Mar 2026 |
| 4 | Vanguard Portfolio Management Llc | 7,487,670 | $197M | Reduced | Jun 2026 |
| 5 | Vanguard Capital Management Llc | 7,337,916 | $193M | — | Jun 2026 |
| 6 | Franklin Resources Inc | 6,894,025 | $175M | Reduced | Mar 2026 |
| 7 | Ilex Capital Partners (Uk) Llp | 4,372,709 | $115M | New | Jun 2026 |
| 8 | Victory Capital Management Inc | 4,393,068 | $111M | Reduced | Mar 2026 |
| 9 | Aqr Capital Management Llc | 4,023,691 | $106M | Added | Jun 2026 |
| 10 | Massachusetts Financial Services Co /ma/ | 2,913,844 | $79M | New | Jun 2026 |
| 11 | Arrowstreet Capital, Limited Partnership | 2,858,293 | $73M | Added | Mar 2026 |
| 12 | Jpmorgan Chase & Co | 2,916,244 | $71M | Reduced | Mar 2026 |
| 13 | Quantinno Capital Management Lp | 2,694,970 | $68M | Added | Mar 2026 |
| 14 | Deerfield Management Company, L.p. | 2,210,100 | $56M | Reduced | Mar 2026 |
| 15 | Bank Of America Corp /de/ | 2,190,485 | $56M | Reduced | Mar 2026 |
| 16 | Norges Bank | 2,051,894 | $54M | New | Jun 2026 |
| 17 | Gotham Asset Management, Llc | 1,765,134 | $47M | Reduced | Jun 2026 |
| 18 | Point72 Asset Management, L.p. | 1,563,395 | $41M | New | Jun 2026 |
| 19 | Northern Trust Corp | 1,616,983 | $41M | Added | Mar 2026 |
| 20 | Pzena Investment Management Llc | 1,604,196 | $41M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$3.95B
Enterprise Value
$4.30B
P/E (TTM)
40.26x
Forward P/E
16.55x
PEG Ratio
-0.74x
P/B
1.26x
P/S
1.38x
P/FCF
17.15x
EV/EBITDA
12.23x
Shares Out
169.2M
Financials (TTM)
Revenue
$2.86B
Net Income
$95.0M
EBITDA
$351.3M
Free Cash Flow
$230.4M
Op Cash Flow
$275.7M
EPS Basic
$0.28
EPS Diluted
$0.58
EPS Forward
$1.41
Gross Margin
55.5%
Op Margin
9.9%
Net Margin
3.3%
Balance Sheet
Total Assets
$5.68B
Total Liab.
$2.57B
Total Equity
$3.11B
Cash
$1.21B
LT Debt
$1.56B
Book Value/Sh
$18.49
Debt/Equity
0.55x
Current Ratio
2.38
Quick Ratio
2.04
Returns & Growth
ROE
1.5%
ROA
0.8%
ROIC
1.2%
Rev Growth YoY
+8.3%
EPS Growth YoY
+104.3%
Price Returns
2W
-13.5%
1M
-14.8%
3M
-8.6%
6M
-6.1%
12M
+12.6%
Technicals
52W High
$30.26
52W Low
$18.95
50d MA
$26.94
200d MA
$25.53
RSI (14)
21.60
ATR (14)
$0.87
Beta
0.98
Avg Volume
2.7M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$27.00
High
$35.00
Low
$19.00
Median
$25.00
Data updated apr 26, 2026 4:21pm
· Source: financialmodelingprep.com